4/8
02:11 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
3/13
12:14 pm
vygr
Rating for VYGR
Low
Report
Rating for VYGR
3/13
08:00 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
3/12
11:26 am
vygr
Rating for VYGR
High
Report
Rating for VYGR
3/12
11:26 am
vygr
Rating for VYGR
High
Report
Rating for VYGR
3/12
10:33 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush.
3/12
10:33 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush.
3/12
10:27 am
vygr
Rating for VYGR
Medium
Report
Rating for VYGR
3/12
10:27 am
vygr
Rating for VYGR
Medium
Report
Rating for VYGR
3/12
10:12 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
3/12
10:10 am
vygr
Rating for VYGR
Medium
Report
Rating for VYGR
3/3
11:40 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
2/11
07:17 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock, down previously from $11.00.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock, down previously from $11.00.
2/11
07:17 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock, down previously from $11.00.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock, down previously from $11.00.
1/27
08:02 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.